Produktname:[2-(2,6-dioxo-3-piperidyl)-3-oxo-isoindolin-5-yl]methyl N-[2-fluoro-4-methyl-5-(trifluoromethoxy)phenyl]carbamate
IUPAC Name:[2-(2,6-dioxopiperidin-3-yl)-3-oxo-2,3-dihydro-1H-isoindol-5-yl]methyl N-[2-fluoro-4-methyl-5-(trifluoromethoxy)phenyl]carbamate
- CAS:2803881-73-2
- Molekulare Formel:C23H19F4N3O6
- Reinheit:95%
- Katalognummer:CM1076470
- Molekulargewicht:509.41
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2803881-73-2
- Molekulare Formel:C23H19F4N3O6
- Schmelzpunkt:-
- SMILES-Code:CC1=C(OC(F)(F)F)C=C(NC(=O)OCC2=CC=C3CN(C4CCC(=O)NC4=O)C(=O)C3=C2)C(F)=C1
- Dichte:
- Katalognummer:CM1076470
- Molekulargewicht:509.41
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- PROTAC-E3 Ligase Ligands
- Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
- PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.